These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37820319)

  • 1. The LET trilemma: Conflicts between robust target coverage, uniform dose, and dose-averaged LET in carbon therapy.
    Fredriksson A; Glimelius L; Bokrantz R
    Med Phys; 2023 Dec; 50(12):7338-7348. PubMed ID: 37820319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose averaged linear energy transfer optimization for large sacral chordomas in carbon ion therapy.
    Schafasand M; Resch AF; Nachankar A; Góra J; Martino G; Traneus E; Glimelius L; Georg D; Fossati P; Carlino A; Stock M
    Med Phys; 2024 Jun; 51(6):3950-3960. PubMed ID: 38696546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of range uncertainty on clinical distributions of linear energy transfer and biological effectiveness in proton therapy.
    Hahn C; Eulitz J; Peters N; Wohlfahrt P; Enghardt W; Richter C; Lühr A
    Med Phys; 2020 Dec; 47(12):6151-6162. PubMed ID: 33118161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of dose-averaged linear energy transfer (LET
    Rana S; Traneus E; Jackson M; Tran L; Rosenfeld AB
    Med Phys; 2022 May; 49(5):3444-3456. PubMed ID: 35194809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing biological effectiveness guided plan optimization strategies for cranial proton therapy: potential and challenges.
    Hahn C; Heuchel L; Ödén J; Traneus E; Wulff J; Plaude S; Timmermann B; Bäumer C; Lühr A
    Radiat Oncol; 2022 Oct; 17(1):169. PubMed ID: 36273132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological Dose Optimization for Particle Arc Therapy Using Helium and Carbon Ions.
    Mein S; Tessonnier T; Kopp B; Schömers C; Harrabi S; Abdollahi A; Debus J; Haberer T; Mairani A
    Int J Radiat Oncol Biol Phys; 2022 Oct; 114(2):334-348. PubMed ID: 35490991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analytical dose-averaged LET calculation algorithm considering the off-axis LET enhancement by secondary protons for spot-scanning proton therapy.
    Hirayama S; Matsuura T; Ueda H; Fujii Y; Fujii T; Takao S; Miyamoto N; Shimizu S; Fujimoto R; Umegaki K; Shirato H
    Med Phys; 2018 Jul; 45(7):3404-3416. PubMed ID: 29788552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of linear energy transfer computed in a Monte Carlo dose engine of a commercial treatment planning system.
    Wagenaar D; Tran LT; Meijers A; Marmitt GG; Souris K; Bolst D; James B; Biasi G; Povoli M; Kok A; Traneus E; van Goethem MJ; Langendijk JA; Rosenfeld AB; Both S
    Phys Med Biol; 2020 Jan; 65(2):025006. PubMed ID: 31801119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton monoenergetic arc therapy (PMAT) to enhance LETd within the target.
    Bertolet A; Carabe A
    Phys Med Biol; 2020 Aug; 65(16):165006. PubMed ID: 32428896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference in LET-based biological doses between IMPT optimization techniques: Robust and PTV-based optimizations.
    Hirayama S; Matsuura T; Yasuda K; Takao S; Fujii T; Miyamoto N; Umegaki K; Shimizu S
    J Appl Clin Med Phys; 2020 Apr; 21(4):42-50. PubMed ID: 32150329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balancing benefits and limitations of linear energy transfer optimization in carbon ion radiotherapy for large sacral chordomas.
    Parrella G; Magro G; Chalaszczyk A; Rotondi M; Ciocca M; Glimelius L; Fiore MR; Paganelli C; Orlandi E; Molinelli S; Baroni G
    Phys Imaging Radiat Oncol; 2024 Jul; 31():100624. PubMed ID: 39206357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the track- and dose-averaged LET and LET spectra in proton therapy using the geant4 Monte Carlo code.
    Guan F; Peeler C; Bronk L; Geng C; Taleei R; Randeniya S; Ge S; Mirkovic D; Grosshans D; Mohan R; Titt U
    Med Phys; 2015 Nov; 42(11):6234-47. PubMed ID: 26520716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robust intensity-modulated proton therapy to reduce high linear energy transfer in organs at risk.
    An Y; Shan J; Patel SH; Wong W; Schild SE; Ding X; Bues M; Liu W
    Med Phys; 2017 Dec; 44(12):6138-6147. PubMed ID: 28976574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Integrated Physical Optimization Framework for Proton Stereotactic Body Radiation Therapy FLASH Treatment Planning Allows Dose, Dose Rate, and Linear Energy Transfer Optimization Using Patient-Specific Ridge Filters.
    Liu R; Charyyev S; Wahl N; Liu W; Kang M; Zhou J; Yang X; Baltazar F; Palkowitsch M; Higgins K; Dynan W; Bradley J; Lin L
    Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):949-959. PubMed ID: 36736634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Planning Strategy to Optimize the Dose-Averaged LET Distribution in Large Pelvic Sarcomas/Chordomas Treated with Carbon-Ion Radiotherapy.
    Nachankar A; Schafasand M; Carlino A; Hug E; Stock M; Góra J; Fossati P
    Cancers (Basel); 2023 Oct; 15(19):. PubMed ID: 37835598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robust optimization to reduce the impact of biological effect variation from physical uncertainties in intensity-modulated proton therapy.
    Bai X; Lim G; Grosshans D; Mohan R; Cao W
    Phys Med Biol; 2019 Jan; 64(2):025004. PubMed ID: 30523932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional dose and LET
    Pirlepesov F; Wilson L; Moskvin VP; Breuer A; Parkins F; Lucas JT; Merchant TE; Faught AM
    Med Phys; 2022 Dec; 49(12):7417-7427. PubMed ID: 36227617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technical note: Investigation of dose and LET
    Yang Y; Rwigema JM; Vargas C; Yu NY; Keole SR; Wong WW; Schild SE; Bues M; Liu W; Shen J
    Med Phys; 2022 Dec; 49(12):7428-7437. PubMed ID: 36208196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linear energy transfer distributions in the brainstem depending on tumour location in intensity-modulated proton therapy of paediatric cancer.
    Fjæra LF; Li Z; Ytre-Hauge KS; Muren LP; Indelicato DJ; Lassen-Ramshad Y; Engeseth GM; Brydøy M; Mairani A; Flampouri S; Dahl O; Stokkevåg CH
    Acta Oncol; 2017 Jun; 56(6):763-768. PubMed ID: 28423966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
    Ödén J; Eriksson K; Toma-Dasu I
    Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.